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Abstract 
______________________________________________________________________________________________________ 
The clinical evolution of a diabetic patient is linked to its compliance with non-
pharmacological measures such as diet, physical activity, acquiring habits, medical controls 
and also with its pharmacological treatment.  
In different Latin American countries such as the Republic of Paraguay, there are National 
Programs to provide free support and treatment to the diabetic population that mostly have 
vulnerable social conditions. However, the impact of these government policies is not 
routinely evaluated. In order to establish the achievements of a state diabetes program, the 
present study was carried out. 
Methodology: This is a descriptive, cross-sectional study with an analytical stage. 
Results: low adherence to non-pharmacological measures such as diet and physical activity 
was detected. A high percentage of patients were overweight (38%) or obese (46.5%). 75% 
of the population enrolled in this study did not comply with the program recommendations 
regarding the time and frequency of physical activities, nor they complied with the minimum 
6 daily meals required. Only 37% of the patients had normal levels of glycated hemoglobin 
and 51.3% of them had pharmacological treatment adherence. Low compliance was 
observed in relation to regular medical examinations (which were under free coverage by the 
program) that are transposed in 22% of retinal studies and 60% in 24-hour urine analysis for 
the early detection of complications such as retinopathy and nephropathy. 
Conclusion: Despite the economic and logistical efforts carried out by State programs in order 
to care of people with diabetes mellitus, data showed a low adherence of patients to the 
proposed pharmacological and non-pharmacological measures. A personalized follow-up 
strategy is necessary to improve treatment adherence and to obtain better therapeutic 
results. 
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INTRODUCTION 
Diabetes Mellitus is a metabolic disease that is manifested by 
abnormal glucose levels in the blood1. Type 2 Diabetes 
Mellitus (DM2) is the one of the most common chronic 
disease in adults, and it occurs when the insulin secreted by 
the pancreas does not cover the needs of the patient2. It 
comprises a group of metabolic disorders characterized by 
chronic hyperglycemia, which is accompanied by secondary 
alterations in many organs, with high morbidity and 
mortality.3 
The three major factors that determine the increase in the 
prevalence of diabetes in the world are a diet rich in simple 
carbohydrates (sugars, fat), a sedentary life and obesity.4-6 
The chronic complications of Diabetes generally are 
developed due to poor illness control, which is related to 
elevate glucose levels and an increase in risk habits 
(sedentary lifestyle and improper diet). These elements are 
associated to complications for patient’s health, such as a 
high risk of coronary artery disease, peripheral vascular 
disease, and stroke.7 
In addition, type 2 diabetic patients are more likely to have 
hypertension and dyslipidemia.7 
Despite the fact that pharmacological treatments with 
antidiabetic agents have grown exponentially in the last 
decades, it should be noted that the first-line treatment must 
be non-pharmacological approaches including diet 
modification, weight control and regular exercise.  
The biggest problem for the health system is the lack of 
patient’s adherence to recommendations referred to lifestyle 
changes or to treatment compliance7. 
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Patient’s adherence rates for non-pharmacological 
approaches in chronic diseases are usually less than 50%, 
although they may vary from country to country8,9. Hence, it 
is important to have local data in each region, in order to 
conduct the right health policies. 
The World Health Organization (WHO) ensures that "non-
compliance with treatment is the main cause of not obtaining 
all the benefits that medical treatment can provide to 
patients"10, and that is why it is reflected in a true public 
health problem, becomes a barrier in disease prevention 
processes and plays a crucial role in the development of 
morbidity and mortality and 10. 
The National Diabetes Program of the Ministry of Public 
Health and Social Welfare of the Republic of Paraguay 
provides adequate tools for the daily management of the 
disease in the diabetic population, however its real health 
impact is still ignored11. In order to estimate the benefit of 
the National Diabetes program in terms of health indicators, 
the present work was performed. 
METHODOLOGY 
Type of Study: It is a descriptive, observational, cross-
sectional study. 
Study Universe: Type 2 diabetic patients benefiting from the 
National Diabetes Program. 
Sample: A sample of program beneficiaries in the capital city 
of Asunción over 40 years old was obtained. 
Data Collection Tool: data was extracted from specific 
questionnaire and from clinical record of patients from the 
National Diabetes Program 
Variables: sex, age, years of disease, HBA1C, cholesterol, 
triglycerides, weight, height, body mass index, fundus, 24-
hour urine test, pharmacological treatment, non-
pharmacological measures; degree of compliance with non-
pharmacological/pharmacological treatment, and 
participation in activities of the National Program were the 
main variables explored. 
A total of 482 patients were enrolled in the study; 73% were 
women and 27% men. Their mean age was 64.96 ± 10.3 
years. 
RESULTS AND DISCUSSION 
Based on the statistical analysis of the questionnaire data, 
and the data extracted from the clinical history, the results 
were classified in each of the treatment pillars established. 
The results on eating habits in relation to the meals that the 
patients reported in study questionnaire showed that 
breakfast, lunch and dinner are the most respected intakes 
(Fig. 1). The 100% of patients complied with breakfast and 
lunch, and 98.8% with dinner. Slightly lower percentages 
were observed in the mid-morning snack (89%), and in the 
afternoon snack (91.5%); while only 50% of the patients had 
accomplished with the night meal. Most of the patients 
reported that the did know how many times a day they 
should eat to comply with the Program’s meal plan, however, 
most of them eat less that the minimum of meals 
recommended (fig. 1). 
 
 
Figure 1: Compliance with recommended daily meals 
 
In relation to the nutritional plan recommended in the 
"National Program" and the type of foods that patients 
included in their diet, the most relevant results showed that 
84.1% and 70.1% of the patients complied with the food 
recommended for breakfast (milk and cereal) respectively. 
Among those who made the morning snack, 75.3% followed 
the recommendation to include in that meal dairy or fruits; 
while at lunch the degree of compliance with the three 
recommended foods was 93.9% for proteins, 72.0% for 
cereals and 84.1% for vegetables, with a very low 
compliance in fruit intake. The inclusion of the 
recommended components in the National Plan for “snacks” 
were heterogeneous (60.9% incorporated milk; 39.1% 
cereals; 23.2% dairy and 33.3% yogurt / fruits); and at 
dinner, only 37% met the recommendations to include 
vegetables. Finally, among those who complied with the 
night snack, 85.7% followed the guidelines of including a 
yogurt in this meal (Fig. 2). 
 
Rodríguez et al                                                                                                                     Journal of Drug Delivery & Therapeutics. 2021; 11(2):58-62 
ISSN: 2250-1177                                                                                      [60]                                                                                         CODEN (USA): JDDTAO 
 
Figure 2: Type of food included in meals 
 
The body mass index (BMI) of the surveyed patients, based 
on the data found in their clinical records, were grouped 
according to the values of “normal weight”, “overweight” and 
“obesity”. The results showed that 46.5% of the patients 
were obese, 38% were overweight, and only 15.5% had a 
normal weight range (Fig. 3). 
 
Figure 3: Body mass index data 
 
The data related to the lipid profile of the patients under 
Diabetes Program were obtained though their clinical 
records and then grouped into cataloged values; for the 
cholesterol "desired", "high risk" and "high risk"; and for 
triglycerides levels "normal", "slightly increased", "high 
level" and "very high level"; according the recommended 
values for total cholesterol and triglycerides respectively. 
Regarding total cholesterol level (TC), most of the patients 
(60.5%) presented a desirable value (less than or equal to 
200 mg/dl), fulfilling one of the metabolic control objectives; 
while 29.6% of the patients presented an acceptable TC 
levels (between 200-239 mg/dl), and 9.9% had 
unacceptable values of TC levels (more than 240 mg/dl). In 
relation to triglycerides (TGC), the results indicated that 
50% of the patients had a normal triglyceride levels (values 
lower than 150 mg/dl), 34.1% had acceptable levels 
between 150-199 mg/dl, while 11% had elevated levels 
(values of 200 to 499 mg/dl), while 4.9% presented values 




Figure 4:  Lipid profile in patients enrolled in National Diabetes Program 
Cholesterol Triglycerides 
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Regarding the lifestyle (alcohol consumption, smoking habit) 
and physical activity of the participants of the National 
Diabetes Program, the results indicated that the majority of 
the patients neither consumed alcoholic beverages (75.6%), 
nor smoked (89%); while only 68.3% of participants 
performed physical activity, although 75% of them this 
activity was irregularly or inadequately according to the 
guidelines established by the program (Fig. 5). 
 
 
Figure 5: Characteristics of the Lifestyle and habits of the participants of the National Diabetes Program 
 
Regarding the pharmacological treatment, 88.7% of the 
participants knew the name of the medicine they were using 
to treat their diabetes, while 73.5% of them knew the generic 
name of the drug. Failure in the continuity of the treatment 
was found in 48.1% of the patients. 
About the type of medication provided by the Program, more 
than half of the patients received metformin, 34% received 
oral hypoglycemic agents, while a large part of the 
participants associated insulin with their oral treatments 
(Fig. 6). In those patients who received insulin, 81.7% 
admitted having received specific education for its use and 
application; however, only 62.9% of them demonstrated 




Figure 6: Type of pharmacological therapy received by participants of the National Diabetes Program 
 
Patient’s attendance to the educational workshops included 
in the Program was dissimilar. 51.2% of the patients 
attended to every educational activity proposed by the 
Program, while the other half of the respondents were 
divided between those who participated to almost all 
activities (7.5%), those who never did so (9.8%), those who 
attended only the first time (11.0%) and those who 
participated occasionally (20.7%). 
The level of knowledge of the patients regarding the 
glycemic values, the guidelines to be follow according to 
those values, and the complications associated with the 
mismanagement of Diabetes was high in all cases (85.4%, 
95.7% and 87.8% respectively). 
To evaluate the evolution of the disease and the treatment 
accomplished in the last month, it was used the glycosylated 
hemoglobin test. 37.3% of the patients had normal levels of 
HbA1C (values less than or equal to 6.5%); 33.3% registered 
acceptable control levels (HbA1C between 6.5 and 8%), and 
29.3% showed unacceptable levels (values higher than 8%). 
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Compliance with the periodical medical controls 
performance was verified in two ways: by a patient’s 
interview and by checking in the clinical records the annual 
mandatory clinical test included in the National Diabetes 
Program (24-hour urine analysis and retinal exam). In these 
practices, there was a disparity of data between the once 
reported by patients and data recorded from medical record. 
45.1% of the patients answered that they had performed 
retinal control in the last year period, while 74.4% of the 
patients self-reported that they performed urine test. 
However, when reviewing the personal medical records, it 
was found that only 22% of the patients did perform a retinal 
examination, and that 60% had carried out a 24-hour 
urinalysis in the last year period. 
The way of how diabetic patients performed their health care 
is associated to the severity of complications due to this 
chronic disease12. Diabetes control is associated to 
economic, environmental, political, and social conditions in 
which people live. Paraguay, as many countries in South 
America is considered low income country where the 
population affected by a disease like diabetes, depend 
directly entirely on the health policies of governments. 
Therefore, having national programs that meet these need is 
not only desirable but highly necessary. But it is not only 
important to have a Program but also to evaluate its 
effectiveness in terms of meeting the proposed guidelines 
and the disease control in order to ensure that the State's 
efforts bear fruit. 
The National Diabetes Program of Paraguay is focused on 
five main pillars: establishing healthy eating habits; 
providing education for disease’s understanding; promoting 
an adequate lifestyle and physical activities among patients; 
guarantee access to free medication treatment, and ensuring 
periodic medical control to avoid complications. 
These aspects are scientifically validated as potential 
modifiers of the ominous course of diabetes over time13-16. 
Hence, adherence to these 5 proposals is well indicator of the 
program's success. However, according to results obtained in 
the study, it can be stand that most of the patients do not 
comply with many of National Diabetes Program guidelines. 
Likewise, in relation to nourishment habits or physical 
activities, 75% of the patients did not accomplish the 
recommendations regarding the time and frequency of meals 
intake or the athletic workout. 
The most important evidence of non-compliance of Program 
recommendations was reflected in the high number of 
overweight (38%) and obese (46.5%) patients. 
Regarding the pharmacological treatment of type II Diabetes 
patients under the Program, although an acceptable 
adherence was evidenced, the insulin requirement in half of 
the patients indicates a therapeutic failure of oral treatments. 
This treatment failure is reflected in the fact that 62.7% of 
the individuals had sub-optimal HbA1C evaluation by 
laboratory analysis. 
The lack of continuity in the medical controls and the low 
compliance of urine renal function test or retinal 
examination, threaten the early detection of complications 
such as retinopathy and nephropathy, which are indicators 
of a progression of the disease. 
This study demonstrated that despite the governmental 
efforts embodied in the National Diabetes Program, the level 
of adherence of patients to the global treatment of diabetes 
was low in relation to the five therapeutic pillars proposed 
by the program (eating habits, style life/physical activities, 
education, drug treatment, and medical controls). It is 
imperative then that this type of health programs should 
nominalized and personalized the follow-up of each patient 
in order to guarantee the compliance to non-pharmacological 
and pharmacological treatments proposed by the program. 
Although this type of personalized follow-up may be 
laborious, the impact in terms of health benefits and in the 
reduction of disease complications will be surely rewarded 
in better health conditions of the diabetic population and in 
costs' reduction for the health system. 
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